Puma Biotechnology reported $258.66M in Assets for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acceleron Pharma XLRN:US $ 875.79M 56.54M
Agios Pharmaceuticals AGIO:US $ 1874.6M 613.83M
Alexion Pharmaceuticals ALXN:US $ 18650.2M 547.2M
Alnylam Pharmaceuticals ALNY:US $ 3255.27M 151.79M
Amgen AMGN:US $ 62539M 409M
Arena Pharmaceuticals ARNA:US $ 1183.94M 6.78M
Array Technologies Inc ARRY:US 583.28M 72.75M
Biogen BIIB:US $ 24470.4M 615.7M
Biomarin Pharmaceutical BMRN:US $ 5898.5M 93.44M
Bluebird Bio BLUE:US $ 1637.28M 143.97M
Cerulean Pharma CERU:US $ 10.52M 2.97M
Clovis Oncology CLVS:US $ 548.84M 56.72M
Daiichi Sankyo 4568:JP Y 2062470M 22708M
Esperion Therapeutics ESPR:US $ 278.61M 74.65M
Exelixis EXEL:US $ 2190.54M 53.21M
Gilead Sciences GILD:US $ 67984M 492M
Glaxosmithkline GSK:US $ 77011M 1068M
Intercept Pharmaceuticals ICPT:US $ 523.22M 3.11M
Macrogenics MGNX:US $ 425.91M 9.53M
Mirati Therapeutics MRTX:US $ 1380.83M 95.3M
Moderna Inc MRNA:US 12.69B 5.36B
Novartis NOVN:VX SF 124015M 2263M
Ptc Therapeutics PTCT:US $ 2058.67M 53.27M
Puma Biotechnology PBYI:US $ 258.66M 14.44M
Regeneron Pharmaceuticals REGN:US $ 17772.2M 608.9M
Sangamo Biosciences SGMO:US $ 877.1M 61.46M
Sarepta Therapeutics SRPT:US $ 2765.23M 219.48M
Seattle Genetics SGEN:US $ 3952.16M 9.17M
Spectrum Pharmaceuticals SPPI:US $ 179.01M 17.79M
Takeda 4502:JP Y 12657234M 255059M
Tg Therapeutics TGTX:US $ 481.4M 67.3M
Ultragenyx Pharmaceutical RARE:US $ 1512.44M 85.32M
Vanda Pharmaceuticals VNDA:US $ 567.64M 24.45M
Vertex Pharmaceuticals VRTX:US $ 12221.69M 106.63M
YTE INCY:US $ 3661.44M 100.52M